Consequences of rpoB mutations missed by the GenoType MTBDRplus assay in a programmatic setting in South Africa

BACKGROUND: Rifampicin resistance missed by commercial rapid molecular assays but detected by phenotypic assays may lead to discordant susceptibility results and affect patient management. OBJECTIVE: This study was conducted to evaluate the causes of rifampicin resistance missed by the GenoType MTBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Mvelase, Nomonde R., Cele, Lindiwe P., Singh, Ravesh, Naidoo, Yeshnee, Giandhari, Jennifer, Wilkinson, Eduan, de Oliveira, Tulio, Swe-Han, Khine Swe, Mlisana, Koleka P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982466/
https://www.ncbi.nlm.nih.gov/pubmed/36873290
http://dx.doi.org/10.4102/ajlm.v12i1.1975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982466/
https://www.ncbi.nlm.nih.gov/pubmed/36873290
http://dx.doi.org/10.4102/ajlm.v12i1.1975

Ejemplares similares